Viewing Study NCT05351593


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2025-12-25 @ 11:31 PM
Study NCT ID: NCT05351593
Status: RECRUITING
Last Update Posted: 2025-02-03
First Post: 2022-04-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
Sponsor: James Rubenstein
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module